Dr. Berrettini is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
113 Cherry Lane
Wynnewood, PA 19096Phone+1 484-432-5836Fax+1 610-642-2740
Summary
- Dr. Wade Berrettini is a psychiatrist and pharmacologist in the Philadelphia area. for the past 25 years he has been a professor of psychiatry at the Perelman School of Medicine, University of Pennsylvania. He received his medical degree from Jefferson Medical College in 1977, and a Phd in pharmacology from Thomas Jefferson University in 1979. He specializes in psychopharmacology of treatment-resistant mood, anxiety and addictive disorders. The author of more than 400 peer-reviewed scientific publications, he has a practice of psychiatry in Wynnewood, PA.
Education & Training
- Clinical Center at the National Institutes of HealthFellowship, Psychosomatic Medicine, 1982 - 1983
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Psychiatry, 1977 - 1980
- Thomas Jefferson UniversityPh.D, Pharmacology, 1977 - 1979
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1977, MD
- Dickinson CollegeBS, Cum Laude, 1969 - 1973
Certifications & Licensure
- PA State Medical License 1978 - 2024
- MD State Medical License 1980 - 1990
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- National Alliance for Research on Schizophrenia and Depression Distinguished Investigator Award 1999, 2004, 2009
- Research Award Caron Foundation, 2009
- GlaxoSmithKline Fellowship in Genetics of Disease 2007
- Join now to see all
Clinical Trials
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 526 citationsGenome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biologyNiamh Mullins, Andreas J. Forstner, Kevin S. O’Connell, Brandon J. Coombes, Jonathan R. I. Coleman
Nature Genetics. 2021-05-17 - 1581 citationsGenetic relationship between five psychiatric disorders estimated from genome-wide SNPsS. Hong Lee, Stephan Ripke, Benjamin M. Neale, Stephen V. Faraone, Shaun Purcell
Nature Genetics. 2013-09-01 - 474 citationsGenomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 SubphenotypesDouglas M. Ruderfer, Stephan Ripke, Andrew McQuillin, James Boocock, Eli A. Stahl
Cell. 2018-06-14
Journal Articles
- Detecting Significant Genotype–Phenotype Association Rules in Bipolar Disorder: Market Research Meets Complex GeneticsJohn Kelsoe, Melvin McInnis, James Potash, William Lawson, John Rice, Evaristus Nwulia, William Byerley, Francis J McMahon, John Nurnberger, Wade Berrettini, Cinnamon ..., Springer Open
- Platelet monoamine oxidase in chronic schizophrenia.Berrettini, W.H., Vogel, W.H. and Clouse, R, American Journal of Psychiatry 134:805-806
- Decreased platelet monoamine oxidase activity in chronic schizophrenia demonstrated with novel substrates.Berrettini, W.H., Prozialeck, W. and Vogel, W.H, Archives of General Psychiatry 35:600-605
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Further evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia.Vogel, W.H., Berrettini, W.H. and Ladman, R.K, Schizophrenia Bulletin 6:232-234
- Platelet MAO in families of chronic schizophrenics.Berrettini, W.H., Benfield, T.C., Schmidt, A.O., Ladman, R.K. and Vogel, W.H, Schizophrenia Bulletin 6:235-237
- Effects of oxygen, pH, and toluene on the activity of platelet MAO obtained from healthy and chronic schizophrenic individuals.Vogel, W.H., Berrettini, W.H., Weiss, K.J. and Benfield, T.C, Psychopharmacology Bulletin l7:28-31
Press Mentions
- Exploration of Shared Genetic Architecture Between Subcortical Brain Volumes and Anorexia NervosaDecember 5th, 2018
- Genome-Wide Association Study of Seasonal Affective DisorderSeptember 14th, 2018
- Yes, You Can Inherit Depression—Here’s What That Means if You're StrugglingMay 16th, 2018
- Join now to see all
Grant Support
- Genetics Of Nicotine DependenceNational Institute On Drug Abuse2009–2012
- MU Opioid Receptor In AddictionNational Institute On Drug Abuse2008–2011
- Linkage Disequilibrium Studies Of Morip Genes In Opiod DependenceNational Institute On Drug Abuse2008–2011
- Administrative CoreNational Institute On Drug Abuse2008–2011
- MU Receptor Interacting Proteins In Opiate DependenceNational Institute On Drug Abuse2007–2011
- A Collaborative Genomic Study Of Bipolar DisorderNational Institute Of Mental Health2004–2007
- Genetics Of Anorexia NervosaNational Institute Of Mental Health2002–2005
- Quantitative Genetics Of Opiate AddictionNational Institute On Drug Abuse2002–2004
- A Neuropeptide Gene In Psychiatric IllnessNational Institute Of Mental Health2002–2004
- MU Receptor Polymorphisms And Heroin AddictionNational Institute On Drug Abuse2002
- Collaborative Genomic Study Of Bipolar DisorderNational Institute Of Mental Health1998–2001
- Genetic Study Of Opioid AddictionNational Institute On Drug Abuse1997–2000
- Quantitative Genetics Of A RAT Model For AlcoholismNational Institute On Alcohol Abuse And Alcoholism1997–1999
- Quantitative Genetics Of Opiate AddictionNational Institute On Drug Abuse1997
- Quantitative Genetics Of A RAT Model For AlcoholismNational Institute On Alcohol Abuse And Alcoholism1996–1997
- Quantitative Genetics Of Opiate AddictionNational Institute On Drug Abuse1995–1997
- Linkage Studies Of Bipolar DiseaseNational Institute Of Mental Health1995–1996
Other Languages
- French, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: